J Korean Neurosurg Soc.  2011 Mar;49(3):147-152.

Validation of Pediatric Functional Assessment of Cancer Therapy Questionnaire (Version 2.0) in Brain Tumor Survivor Aged 13 Years and Older (Parent Form)(PedsFACT-BrS Parent of Adolescent)

Affiliations
  • 1Department of Neurosurgery, Asan Medical Center, Ulsan University of Medicine, Seoul, Korea.
  • 2Department of Neurosurgery, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea. dskim33@yuhs.ac
  • 3Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • 4Department of Pediatrics, Seoul National University Hospital, Seoul, Korea.

Abstract


OBJECTIVE
The aim of this study was to evaluate the reliability and validity of the Pediatric Functional Assessment of Cancer Therapy Questionnaire Brain Tumor Survivor (version 2.0) Aged 13 years and older (Parent Form) (pedsFACT-BrS parent of adolescent).
METHODS
The pedsFACT-BrS parent of adolescent was translated and cross-culturally adapted into Korean, following standard Functional Assessment of Chronic Illness Therapy (FACIT) methodology. The psychometric properties of the pedsFACT-BrS parent of adolescent were evaluated in 170 brain tumor patient's mothers (mean age=43.38 years). Pretesting was performed in 30 mothers, and the results indicated good symptom coverage and overall comprehensibility. The participants also completed the Child Health Questionnaire Parent Form 50 (CHQ-PF-50), Neuroticism in Eysenck Personality Questionnaire, and Karnofsky score.
RESULTS
In validating the pedsFACT-BrS parent of adolescent, we found high internal consistency, with Cronbach's alpha coefficients ranging from 0.76 to 0.94. The assessment of test-retest reliability using intraclass correlation coefficient revealed satisfactory values with ICCs ranging from 0.84 to 0.93. The pedsFACT-BrS for parent of adolescent also demonstrated good convergent and divergent validities when correlated with the Child Health Questionnaire Parent Form 50 (CHQ-PF-50) and the Neuroticism in Eysenck Personality Questionnaire. The pedsFACT-BrS parent of adolescent showed good clinical validity, and effectively differentiated between clinically distinct patient groups according to the type of treatment, tumor location, shunt, and Karnofsky score of parent proxy report.
CONCLUSION
We confirmed that this reliable and valid instrument can be used to properly evaluate the quality of life of Korean adolescent brain tumor patients by their parents' proxy report.

Keyword

Quality of life; Adolescent brain tumor patient; pedsFACT-BrS parent of adolescent; Validity

MeSH Terms

Adolescent
Aged
Anxiety Disorders
Brain
Brain Neoplasms
Child
Child Health
Chronic Disease
Humans
Mothers
Parents
Proxy
Psychometrics
Quality of Life
Surveys and Questionnaires
Reproducibility of Results
Survivors
Anxiety Disorders
Full Text Links
  • JKNS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr